Ultrasound-guided injection of botulinum toxin A in the treatment of iliopsoas spasticity

Journal of Ultrasound

Volumn 11, Issue 3, 2008, Pages 113-117

  Sconfienza, L M ^a   Perrone, N ^a   Lacelli, F ^b   Lentino, C ^b   Serafini, G ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b AO Ospedale Santa Corona   (Italy)

Author keywords

Botulinum A toxin; Cerebral palsy; Iliopsoas muscle; Injection; Interventional ultrasonography

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DYSTONIA; HUMAN; ILIAC BONE; ILIOPSOAS MUSCLE; ILIOPSOAS SPASTICITY; INJECTION SITE; INTERVENTIONAL RADIOLOGY; NEEDLE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; PSOAS MUSCLE; SINGLE DRUG DOSE; SPASTICITY; ULTRASOUND;

EID: 51249092808     PISSN: 19713495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jus.2008.05.002     Document Type: Article

References (25)

1. Erbguth F.J. From poison to remedy: the chequered history of botulinum toxin. J Neural Transm 115 4 (2008) 559-565
2. Erbguth F.J. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19 Suppl. 8 (2004) S2-S6
3. Kessler K.R., Skutta M., and Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. J Neurol 246 (1999) 265-274
4. Bakheit A.M., Severa S., Cosgrove A., et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol 43 (2001) 234-238
5. Kirschner J., Berweck S., Mall V., Korinthenbeg R., and Heinen F. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol 248 Suppl. 1 (2001) 28-30
6. Westhoff B., Seller K., Wild A., Jaeger M., and Krauspe R. Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle. Dev Med Child Neurol 45 12 (2003 Dec) 829-832
7. Vles G.F., de Louw A.J., and Speth L.A. Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice. Eur J Paediatr Neurol 12 3 (2008) 231-238
8. Scott A.B., Rosenbaum A., and Collins C.C. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12 (1973) 924-927
9. Deleplanque B., Lagueny A., Flurin V., et al. Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children. Rev Chir Orthop Reparatrice Appar Mot 88 (2002) 279-285
10. Molenaers G., Eyssen M., Desloovere K., Jonkers I., and De Cock P. A multilevel approach to botulinum toxin type A treatment of the (ilio)psoas in spasticity in cerebral palsy. Eur J Neurol 6 Suppl. 4 (1999) 59-62
11. Dutton J.J., and Fowler A.M. Botulinum toxin in ophthalmology. Surv Ophtalmol 52 1 (2007) 13-31
12. Jones O.M. Towards safer treatments for benign anorectal disease: the pharmacological manipulation of the internal anal sphincter. Ann R Coll Surg Engl 89 6 (2007) 574-579
13. Watts C.R., Truong D., and Nye C. Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs. J Neural Transm 115 4 (2008) 625-630
14. Schnider P., Binder M., Kittler H., Steinhoff N., and Auff E. Uses of botulinum toxin. Lancet 349 (1997) 953
15. Raval T.H., and Elliott C.A. Botulinum toxin injection to the salivary glands for the treatment of sialorrhea with chronic aspiration. Ann Otol Rhinol Laryngol 117 2 (2008 Feb) 118-122
16. Lew H.L., Lee E.H., Castaneda A., Klima R., and Date E. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 89 1 (2008 Jan) 75-80
17. Sator P.G. Skin treatments and dermatological procedures to promote youthful skin. Clin Interv Aging 1 1 (2006) 51-56
18. Kinnet D. Botulinum toxin A injections in children: technique and dosing issues. Am J Phys Med Rehabil 83 Suppl. 10 (2004) s59-s64
19. Costa J., Espírito-Santo C., Borges A., et al. Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 1 (2005) CD004315
20. Ward A.B. Botulinum toxin type A treatment of hip and thigh spasticity: a technique for injection of psoas major muscle. Eur J Neurol 6 Suppl. 4 (1999) 91-93
21. Willenborg M.J., Shilt J.S., Smitz B.P., Estrada R.L., Castle J.A., and Koman L.A. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum A toxin injection in cerebral palsy. J Pediatr Orthop 22 (2002) 165-168
22. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85 (2000) 101-105
23. Bohannon R.W., and Smith M.B. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67 2 (1987) 206-207
24. Mahoney F.D., and Barthel D.W. Functional evaluation: the Barthel index. MD State Med J 145 (1965) 61-63
25. Katz S., Ford A.B., Moskovitz R.W., Jackson B.A., and Jaffe M.W. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 185 (1963) 914-919